Tradestie Institutional Equity Comparison Engine

CGEN vs MTLS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CGEN Overall Edge

CGEN Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Compugen Ltd (CGEN) driven by superior Valuation, Growth & Margin, Options & Structure while MTLS counters with relative strength in Momentum & Technical. Fundamentally, CGEN trades at 12.4x Forward P/E with 41.3% operating margin (+102.1% YoY revenue) versus MTLS at N/M Forward P/E and 3.4% operating margin (+2.1% YoY). In options structure, CGEN sits in BREAKDOWN (57th %ile IV; Dealer Gamma Walls on Pro) against MTLS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner CGEN
CGEN 12.4x vs MTLS N/M Fwd P/E
Growth & Margin Winner CGEN
Op Margin 41.3% vs 3.4% ยท YoY +102.1% vs +2.1%
Momentum & Technical Winner MTLS
1Y +23.2% vs +4.5% ยท 52W Pos 33% vs 37%
Options & Structure Winner CGEN
BREAKDOWN (57th %ile IV) vs UNCLASSIFIED (N/A IV)
CGEN NASDAQ
Compugen Ltd
Biological Products, (No Diagnostic Substances)
$2.02
-0.98% 1D
Market Cap $193.2M
1M Return +2.54%
1Y Return +23.17%
Forward P/E 12.4x
Unified AI Score
47.1 / 100 HOLD
Tech 44.0 Fund 52.0 Flow 54.0 Mom 64.0
MTLS NASDAQ
Materialise NV
Services-Prepackaged Software
$6.28
+1.13% 1D
Market Cap $355.1M
1M Return -22.52%
1Y Return +4.49%
Forward P/E N/M
Unified AI Score
53.5 / 100 HOLD
Tech 53.0 Fund 53.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CGEN +23.17% MTLS +4.49% Spread: +18.68 pp (CGEN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CGEN TTM Op. Margin: 41.3% MTLS TTM Op. Margin: 3.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CGEN vs MTLS. Trailing 12-month operating profitability (CGEN 41.3% vs MTLS 3.4%) and valuation multiples (CGEN 12.4x vs MTLS N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CGEN (7) vs MTLS (3)
Institutional Metric CGEN MTLS Criterion Row Winner
Market Capitalization Scale $193.2M $355.1M Larger Scale MTLS
Trailing P/E Ratio Valuation 5.2x 24.0x Lower Multiple CGEN
Forward P/E Ratio Valuation 12.4x N/M Lower Multiple CGEN
Revenue Growth (YoY) Growth +102.1% +2.1% Higher Growth CGEN
Operating Margin (TTM) Profitability 41.3% 3.4% Higher Margin CGEN
Net Profit Margin Profitability 47.9% 4.6% Higher Margin CGEN
Return on Equity (ROE) Capital Efficiency 57.2% 5.0% Higher ROE CGEN
52-Week Range Position Momentum 33% ($1โ€“$3) 37% ($5โ€“$9) Stronger Trend MTLS
Beta / 30D Volatility Risk Regime 1.44ฮฒ ยท 62% Vol 1.10ฮฒ ยท 88% Vol Lower Realized Risk CGEN
Unified Institutional Score Composite Signal 47.1 / 100 (HOLD) 53.5 / 100 (HOLD) Higher Composite MTLS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CGEN vs MTLS Buy Guide
CGEN BREAKDOWN
143d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 57th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live CGEN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MTLS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MTLS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CGEN nor MTLS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.